<DOC>
	<DOCNO>NCT01819948</DOCNO>
	<brief_summary>The purpose study determine whether administration PhytoMed™ complement reduces CRP woman histologically confirm AJCC Stage 0-IIIA breast cancer completely surgically resect without evidence disease determine physician</brief_summary>
	<brief_title>Changes Biomarkers Cancer Women With Breast Cancer Without Evidence Disease Who Were Given PhytoMed™</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Women histologically confirm AJCC Stage 0IIIA breast cancer completely surgically resect . No evidence disease determine physician . ER+ and/or PR+ tumour . Receiving aromatase inhibitor ( letrozole , anastrazole , exemestane ) tamoxifen stable dose least 3 month trial entry . Postmenopausal woman , define : ( 1 ) 50 year age menstruate precede 12 month folliclestimulating hormone level ( FSH ) &gt; 40 IU/L , ( 2 ) 50 year age FSH hormone level &gt; 40 IU/L , ( 3 ) undergone bilateral oophorectomy . CRP ≥3.9 mg/L measure mean two consecutive weekly test . Aged 18 year old ECOG performance status 01 Between 2 5 year initial surgery breast cancer . Life expectancy least 6 month At least 6 month since last chemotherapy Laboratory test perform within 14 day trial starting : 1 . Granulocytes ≥ 1,500/µL ; 2 . Platelets ≥ 100,000/µL ; 3 . Haemoglobin ≥ 12.0 g/dL ; 4 . Total bilirubin equal upper limit normal ( ULN ) ; 5 . AST ALT equal ULN ; 6 . Alkaline phosphatase equal ULN ; 7 . Serum creatinine equal ULN ; Able provide inform consent receive trial treatment , provide biological specimen , selfadminister oral medication unsupervised prolonged period time , complete medication diary . Pregnancy breastfeed Who malignancy ( breast cancer ) require radiotherapy systemic treatment within past 5 year . Known cardiac disease ( arrhythmias , myocardial infarction , bundle branch block , ischemic heart disease , uncontrolled hypertension ) Known autoimmune disease inflammatory disorder Any condition requiring use systemic corticosteroid immunosuppressive agent ( e.g . cyclosporin , tacrolimus , azathioprine ) . Women known immunodeficiency ( HIV ) . Patients infection septicaemia , infection , acute hepatitis , uncontrolled severe medical condition Routine use aspirin &gt; 81 mg/d NSAIDs ( &gt; 400 mg po 4 times/day ibuprofen naproxen &gt; 500 mg/d ) use celecoxib similar COX2 inhibitor ; Subjects ask take dietary supplement , olive olive oil 1 month prior trial enrolment trial . Who take bisphosphonates</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Breast cancer</keyword>
	<keyword>Stage 0-IIIA</keyword>
	<keyword>No evidence disease</keyword>
</DOC>